12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 6 05:05

Mizuho Securities Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating, Cuts Target Price to $16

Futu NewsNov 23 03:31 · Ratings

Mizuho Securities Cuts Price Target on Adverum Biotechnologies to $16 From $20, Outperform Rating Maintained

MT NewswiresNov 23 02:28 · Ratings

Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 21 05:05

Express News | Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 21 05:05

Truist Financial Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating

Futu NewsNov 19 20:33 · Ratings